Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Molecular Pain
Published in: Molecular Pain 1/2009

Open Access 01-12-2009 | Research

Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation

Authors: Edgar Alfonso Romero-Sandoval, Ryan Horvath, Russell P Landry, Joyce A DeLeo

Published in: Molecular Pain | Issue 1/2009

Login to get access

Abstract

Background

Cannabinoid receptor type 2 (CBR2) inhibits microglial reactivity through a molecular mechanism yet to be elucidated. We hypothesized that CBR2 activation induces an anti-inflammatory phenotype in microglia by inhibiting extracellular signal-regulated kinase (ERK) pathway, via mitogen-activated protein kinase-phosphatase (MKP) induction. MKPs regulate mitogen activated protein kinases, but their role in the modulation of microglial phenotype is not fully understood.

Results

JWH015 (a CBR2 agonist) increased MKP-1 and MKP-3 expression, which in turn reduced p-ERK1/2 in LPS-stimulated primary microglia. These effects resulted in a significant reduction of tumor necrosis factor-α (TNF) expression and microglial migration. We confirmed the causative link of these findings by using MKP inhibitors. We found that the selective inhibition of MKP-1 by Ro-31-8220 and PSI2106, did not affect p-ERK expression in LPS+JWH015-treated microglia. However, the inhibition of both MKP-1 and MKP-3 by triptolide induced an increase in p-ERK expression and in microglial migration using LPS+JWH015-treated microglia.

Conclusion

Our results uncover a cellular microglial pathway triggered by CBR2 activation. These data suggest that the reduction of pro-inflammatory factors and microglial migration via MKP-3 induction is part of the mechanism of action of CBR2 agonists. These findings may have clinical implications for further drug development.
Appendix
Available only for authorised users
Literature
1.
Hanisch UK, Kettenmann H: Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10: 1387–1394. 10.1038/nn1997PubMedCrossRef
2.
Kreutzberg GW: Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19: 312–318. 10.1016/0166-2236(96)10049-7PubMedCrossRef
3.
De Leo JA, Tawfik VL, LaCroix-Fralish ML: The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 2006, 122: 17–21. 10.1016/j.pain.2006.02.034PubMedCrossRef
4.
Tanga FY, Nutile-McMenemy N, DeLeo JA: The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci USA 2005, 102: 5856–5861. 10.1073/pnas.0501634102PubMedCentralPubMedCrossRef
5.
Romero-Sandoval EA, Nutile-McMenemy N, DeLeo JA: Microglia Cannabinoid Receptor Type 2 Activation Reduces Cytokine and Nitric Oxide Production by Modulating Mitogen-Activated Protein Kinase-Phosphatase (MKP) and Extracellular Signal-Regulated Kinase (ERK). 17th Neuropharmacology Conference, Cannabinoid Signaling in the Nervous System, October 31st – November 2nd, San Diego, USA 2007.
6.
Raghavendra V, Tanga FY, DeLeo JA: Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 2004, 20: 467–473. 10.1111/j.1460-9568.2004.03514.xPubMedCrossRef
7.
Zhao P, Waxman SG, Hains BC: Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci 2007, 27: 2357–2368. 10.1523/JNEUROSCI.0138-07.2007PubMedCrossRef
8.
Ashton JC, Friberg D, Darlington CL, Smith PF: Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett 2006, 396: 113–116. 10.1016/j.neulet.2005.11.038PubMedCrossRef
9.
Nunez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonzalez S, Tolon RM, Romero J: Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 2004, 53: 208–213. 10.1002/syn.20050PubMedCrossRef
10.
Sheng WS, Hu S, Min X, Cabral GA, Lokensgard JR, Peterson PK: Synthetic cannabinoid WIN55,212–2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia 2005, 49: 211–219. 10.1002/glia.20108PubMedCrossRef
11.
Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML: Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 2005, 25: 1904–1913. 10.1523/JNEUROSCI.4540-04.2005PubMedCrossRef
12.
Romero-Sandoval A, Eisenach JC: Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision. Anesthesiology 2007, 106: 787–794. 10.1097/01.anes.0000264765.33673.6cPubMedCrossRef
13.
Romero-Sandoval A, Nutile-McMenemy N, DeLeo JA: Spinal microglial and perivascular cell cannabinoid receptor type 2 activation reduces behavioral hypersensitivity without tolerance after peripheral nerve injury. Anesthesiology 2008, 108: 722–734. 10.1097/ALN.0b013e318167af74PubMedCentralPubMedCrossRef
14.
Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S: Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci 2000,113(Pt 17):3073–3084.PubMed
15.
Ohsawa K, Imai Y, Sasaki Y, Kohsaka S: Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem 2004, 88: 844–856.PubMedCrossRef
16.
Ehrhart J, Obregon D, Mori T, Hou H, Sun N, Bai Y, Klein T, Fernandez F, Tan J, Shytle RD: Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation 2005, 2: 29. 10.1186/1742-2094-2-29PubMedCentralPubMedCrossRef
17.
Klegeris A, Bissonnette CJ, McGeer PL: Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol 2003, 139: 775–786. 10.1038/sj.bjp.0705304PubMedCentralPubMedCrossRef
18.
Zhuang ZY, Gerner P, Woolf CJ, Ji RR: ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114: 149–159. 10.1016/j.pain.2004.12.022PubMedCrossRef
19.
Katsura H, Obata K, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, Fukuoka T, Sakagami M, Noguchi K: Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J Neurosci 2006, 26: 8680–8690. 10.1523/JNEUROSCI.1771-06.2006PubMedCrossRef
20.
Daulhac L, Mallet C, Courteix C, Etienne M, Duroux E, Privat AM, Eschalier A, Fialip J: Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms. Mol Pharmacol 2006, 70: 1246–1254. 10.1124/mol.106.025478PubMedCrossRef
21.
Bhat NR, Zhang P, Lee JC, Hogan EL: Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 1998, 18: 1633–1641.PubMed
22.
Winkelstein BA, Rutkowski MD, Sweitzer SM, Pahl JL, DeLeo JA: Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J Comp Neurol 2001, 439: 127–139. 10.1002/cne.2000PubMedCrossRef
23.
Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA: Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997, 137: 481–492. 10.1083/jcb.137.2.481PubMedCentralPubMedCrossRef
24.
Pullikuth AK, Catling AD: Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell Signal 2007, 19: 1621–1632. 10.1016/j.cellsig.2007.04.012PubMedCentralPubMedCrossRef
25.
Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM: Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J 1996, 15: 3621–3632.PubMedCentralPubMed
26.
Kawakami Y, Rodriguez-Leon J, Koth CM, Buscher D, Itoh T, Raya A, Ng JK, Esteban CR, Takahashi S, Henrique D, et al.: MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat Cell Biol 2003, 5: 513–519. 10.1038/ncb989PubMedCrossRef
27.
Kim Y, Rice AE, Denu JM: Intramolecular dephosphorylation of ERK by MKP3. Biochemistry 2003, 42: 15197–15207. 10.1021/bi035346bPubMedCrossRef
28.
Zhou Y, Ling EA, Dheen ST: Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J Neurochem 2007, 102: 667–678. 10.1111/j.1471-4159.2007.04535.xPubMedCrossRef
29.
Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, Ullrich O: The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 2006, 49: 67–79. 10.1016/j.neuron.2005.11.027PubMedCrossRef
30.
Valledor AF, Xaus J, Comalada M, Soler C, Celada A: Protein kinase C epsilon is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol 2000, 164: 29–37.PubMedCrossRef
31.
Han IO, Kim HS, Kim HC, Joe EH, Kim WK: Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells. J Neurosci Res 2003, 73: 659–669. 10.1002/jnr.10706PubMedCrossRef
32.
Pyo H, Jou I, Jung S, Hong S, Joe EH: Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport 1998, 9: 871–874. 10.1097/00001756-199803300-00020PubMedCrossRef
33.
Nutile-McMenemy N, Elfenbein A, Deleo JA: Minocycline decreases in vitro microglial motility, beta(1)-integrin, and Kv1.3 channel expression. J Neurochem 2007, 103: 2035–46. 10.1111/j.1471-4159.2007.04889.xPubMedCrossRef
34.
Gong Y, Xue B, Jiao J, Jing L, Wang X: Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia. J Neurochem 2008, 107: 779–788. 10.1111/j.1471-4159.2008.05653.xPubMedCrossRef
35.
Jiao J, Xue B, Zhang L, Gong Y, Li K, Wang H, Jing L, Xie J, Wang X: Triptolide inhibits amyloid-beta1–42-induced TNF-alpha and IL-1beta production in cultured rat microglia. J Neuroimmunol 2008, 205: 32–36. 10.1016/j.jneuroim.2008.08.006PubMedCrossRef
36.
Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, Liu Y: Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol 2002, 169: 6408–6416.PubMedCrossRef
37.
Zhao Q, Shepherd EG, Manson ME, Nelin LD, Sorokin A, Liu Y: The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem 2005, 280: 8101–8108. 10.1074/jbc.M411760200PubMedCrossRef
38.
Sorkin LS, Xiao WH, Wagner R, Myers RR: Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997, 81: 255–262. 10.1016/S0306-4522(97)00147-4PubMedCrossRef
39.
40.
Svensson CI, Schafers M, Jones TL, Powell H, Sorkin LS: Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci Lett 2005, 379: 209–213. 10.1016/j.neulet.2004.12.064PubMedCrossRef
41.
Kurpius D, Nolley EP, Dailey ME: Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus. Glia 2007, 55: 873–884. 10.1002/glia.20509PubMedCrossRef
42.
Salter MW, Hicks JL: ATP-evoked increases in intracellular calcium in neurons and glia from the dorsal spinal cord. J Neurosci 1994, 14: 1563–1575.PubMed
43.
Werry EL, Liu GJ, Bennett MR: Glutamate-stimulated ATP release from spinal cord astrocytes is potentiated by substance P. J Neurochem 2006, 99: 924–936. 10.1111/j.1471-4159.2006.04133.xPubMedCrossRef
44.
Sawynok J, Downie JW, Reid AR, Cahill CM, White TD: ATP release from dorsal spinal cord synaptosomes: characterization and neuronal origin. Brain Res 1993, 610: 32–38. 10.1016/0006-8993(93)91213-CPubMedCrossRef
45.
Franklin A, Parmentier-Batteur S, Walter L, Greenberg DA, Stella N: Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci 2003, 23: 7767–7775.PubMed
46.
Franklin A, Stella N: Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol 2003, 474: 195–198. 10.1016/S0014-2999(03)02074-0PubMedCrossRef
47.
Horvath RJ, Nutile-McMenemy N, Alkaitis MS, Deleo JA: Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J Neurochem 2008, 107: 557–69. 10.1111/j.1471-4159.2008.05633.xPubMedCentralPubMedCrossRef
48.
Muccioli GG, Xu C, Odah E, Cudaback E, Cisneros JA, Lambert DM, Lopez Rodriguez ML, Bajjalieh S, Stella N: Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci 2007, 27: 2883–2889. 10.1523/JNEUROSCI.4830-06.2007PubMedCrossRef
49.
Witting A, Chen L, Cudaback E, Straiker A, Walter L, Rickman B, Moller T, Brosnan C, Stella N: Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc Natl Acad Sci USA 2006, 103: 6362–6367. 10.1073/pnas.0510418103PubMedCentralPubMedCrossRef
50.
Dirikoc S, Priola SA, Marella M, Zsurger N, Chabry J: Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity. J Neurosci 2007, 27: 9537–9544. 10.1523/JNEUROSCI.1942-07.2007PubMedCrossRef
51.
Romero-Sandoval EA, Horvath RJ, DeLeo JA: Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs 2008, 9: 726–734.PubMedCentralPubMed
52.
Lazo JS, Skoko JJ, Werner S, Mitasev B, Bakan A, Koizumi F, Yellow-Duke A, Bahar I, Brummond KM: Structurally unique inhibitors of human mitogen-activated protein kinase phosphatase-1 identified in a pyrrole carboxamide library. J Pharmacol Exp Ther 2007, 322: 940–947. 10.1124/jpet.107.122242PubMedCrossRef
53.
Chen TH, Kao YC, Chen BC, Chen CH, Chan P, Lee HM: Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells. Eur J Pharmacol 2006, 541: 138–146. 10.1016/j.ejphar.2006.05.002PubMedCrossRef
54.
Shepherd EG, Zhao Q, Welty SE, Hansen TN, Smith CV, Liu Y: The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J Biol Chem 2004, 279: 54023–54031. 10.1074/jbc.M408444200PubMedCrossRef
55.
Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB: ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005, 8: 752–758. 10.1038/nn1472PubMedCrossRef
56.
Montecucco F, Burger F, Mach F, Steffens S: CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol 2008, 294: H1145–1155. 10.1152/ajpheart.01328.2007PubMedCrossRef
Metadata
Title
Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation
Authors
Edgar Alfonso Romero-Sandoval
Ryan Horvath
Russell P Landry
Joyce A DeLeo
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Molecular Pain / Issue 1/2009
Electronic ISSN: 1744-8069
DOI
https://doi.org/10.1186/1744-8069-5-25

Other articles of this Issue 1/2009

Molecular Pain 1/2009 Go to the issue

Research

The endogenous hydrogen sulfide producing enzyme cystathionine-β synthase contributes to visceral hypersensitivity in a rat model of irritable bowel syndrome

Research

Characterization of intrinsic properties of cingulate pyramidal neurons in adult mice after nerve injury

Short report

In vivo evidence that truncated trkB.T1 participates in nociception

Research

Nociception-induced spatial and temporal plasticity of synaptic connection and function in the hippocampal formation of rats: a multi-electrode array recording

Research

An in vivo mouse model of long-term potentiation at synapses between primary afferent C-fibers and spinal dorsal horn neurons: essential role of EphB1 receptor

Research

Differential role of the menthol-binding residue Y745 in the antagonism of thermally gated TRPM8 channels